Dr Beaini has undertaken much research over the years. Here are a few extracts:
- J Affect Disord. 1980 Jun;2(2):89-94.
A re-examination of the clinical effects of imipramine and amitriptyline in depressive illness.
Beaini AY, Hindmarch I, Snaith RP.
Link to Medline Article
- Br J Psychiatry. 1985 Jul;147:30-5.
Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives.
Bowie PC, Beaini AY.
Link to Medline Article
- Br J Psychiatry. 1987 Jun;150:787-90.
The prognosis of primary depressive illness. Its relationship to the dexamethasone suppression test.
Bowie PC, Beaini AY, Bowie LJ.
Link to Medline Article
- Planning a General Adult Psychiatric Service. Psychiatric Opinion, Number 4, June 1985. A.Y. Beaini.
- Planning a General Adult Psychiatric Service. Psychiatric Opinion, Number 5, September 1985. A.Y.Beaini.
- Bulletin of Royal College of Psychiatrists 1987 November 328-330
The use of EEG in clinical psychiatry
P C W Bowie, A Y Beaini and A A Da Costa
- Addiction Biology (2000) 5,451-462
A Compressed Opiate detoxification regime with Naltrexone maintenance:
A.Y.Beaini, T.S.Johnson, P.Langstaff, M.P.Carr, J.N.Crossfield & R.C.Sweeney
- Br J Ophthalmol. 2004 Sep;88(9):1186-90
Orthoptic status before and immediately after heroin detoxification.
Firth AY, Pulling S, Carr MP, Beaini AY.
OTHER RESEARCH ACTIVITIES
- A pilot study on depression and anxiety measures, in relation to age, in primary depressive illness. A.Y. Beaini and R.P. Snaith.
- Depression and anxiety measures in primary depressive illness – a much larger population. A. Constantopoulos, A.Y. Beaini and R.P. Snaith.
- Double blind placebo controlled trial to assess the efficiency of Naloxone in chronic schizophrenics with persistent auditory hallucinations.
- Assessment of self-poisoning: psychiatrist or houseman? A 20 patient pilot study.
- Several research projects carried out by junior medical staff as part of the M.Med.Sc 3rd year dissertation were jointly supervised by myself and the University Department of Psychiatry.
- A three year research project on the management of self-poisoning, a comparative study including a psychiatric hospital and two psychiatric units. L.J. Bowie and A.Y. Beaini.
- Antidepressive effect of Amitriptyline treatment with plasma levels controlled within three different ranges. Psychopharmacology 94 (1988), 197-205. J.R. Birch and A.Y. Beaini.
- The use of CT scan in General Adult Psychiatry.
C. Cruikshank, A.Y. Beaini and T.S. Brown, joint research with Radiology Department at Bradford Royal Infirmary.
- A review of access and contact between children taken into care and their origins.
A.Y. Beaini and R. Ough.
- Assessment of brain damage/dysfunction.
A.Y. Beaini and S. Bennett.
- Cost effectiveness/quality of care: a comparative study including inpatient and day unit treatment in more than one set up.
A.Y. Beaini and M. Courtney.
- Sandostatin in Naltrexone assisted opiate detoxification, under sedation. J.N. Crossfield and A.Y.Beaini.
Presented at the 6th International Conference of the Stapleford Centre, The Stapleford Trust at the Royal Society of Medicine on 11 & 12 April 2001
Conference title: “Advances in Antagonist Assisted Abstinences: Rapid Opiate Detoxification and Naltrexone Treatments" - Podium presentation
- A double blind, parallel group, placebo controlled trial to investigate the effect of "additional analgesia" on opiate withdrawal symptoms experienced during a compressed opiate detoxification programme. A. Y. Beaini, Chief Investigator.
- Supervised External SSC 2009, University of Bristol. "A retrospective study into the use of tranquilisers during a Naltrexone opiate detoxification regime".
- Supervised Richard Webster in his External SSC Report 2009. "An investigation into major tranquiliser use during compressed opiate detoxification".
- A retrospective study of patients detoxifying from opiate drug use with underlying comorbidities. Amal Y. Beaini. Paper and presentation abstracts. Integrating practice and policy: Everyone's business.
- 15th National Conference. Working with drug and alcohol users in primary care. April 2010, Glasgow.
- A retrospective yearly audit review of safety, effectiveness and percentage of dual diagnosis over a period of 20 years (1998-2018), covering over 8,000 (eight thousand) detoxed and treated patients based on BONDS protocol.
Results: Safety and effectiveness confirmed percentage of dual diagnosis (concomitant substance misuse and mental health disorders) varied from year to year within the 30% - 70% with an approximate average of 50%.
- Neurodevelopmental disorders.
- Addiction and dual diagnosis.
- Distinction Merit Award - National Health Service, October 1988
- Elected Fellow of the Royal Society of Medicine FRSM, 1995
- Life Long Fellow of the Royal Society of Medicine, 2008